首页> 美国卫生研究院文献>Drug Delivery >Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide
【2h】

Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide

机译:促脯氨酸衍生物模板介孔二氧化硅的仿生合成用于增加二嗪泮的脑分布并改善尼菊酯的药效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Herein a new kind of proline-derivative templated mesoporous silica with curved channels (CMS) was biomimetically synthesized and applied as carrier to improve the drug dissolution and bioavailability of hydrophobic diazepam (DZP) and nimesulide (NMS). Drugs can be incorporated into CMS with high efficiency; during this process, they successfully transformed to amorphous phase. As a result, the dissolution rate of DZP and NMS was significantly improved. Biodistribution study confirmed that CMS converted DZP distribution in mice with the tendency of lung targeting and brain targeting. At 45 min postadministration, the concentrations of DZP in plasma, lung and brain were 8.57-fold, 124.94-fold and 19.55-fold higher from 1:3 DZP/CMS sample than that of pure DZP sample, respectively. At 90 min postadministration, the content of DZP in brain was 62.31-fold higher for 1:3 DZP/CMS sample than that of pure DZP. Besides, the anti-inflammatory and analgesic effects of 1:3 NMS/CMS were systematic evaluated using mouse ankle swelling test (MAST), mouse ear swelling test (MEST) and mouse writhing test (MWT). The results indicated that after incorporating into CMS, the therapeutic effects of NMS were obviously improved, and the inhibition rates of 1:3 NMS/CMS in all pharmacodynamics tests varied from 102.2% to 904.3%.
机译:在此,具有曲线通道(CMS)的新种类的脯氨酸衍生物模板介孔二氧化硅被生物地合成并用作载体以改善疏水性二氮酸苄戊类(DZP)和尼米蛋白(NMS)的药物溶解和生物利用度。药物可以以高效率纳入CMS;在此过程中,它们成功转变为非晶阶段。结果,DZP和NMS的溶出速率显着改善。生物分布研究证实,CMS在小鼠中转化了DZP分布,肺靶向和脑靶向的趋势。在45分钟后,血浆中DZP的浓度分别为8.57倍,124.94倍和19.55倍,分别比纯DZP样品的1:3 DZP / CMS样品更高。在90分钟后,脑中DZP的含量比纯DZP的1:3 DZP / CMS样本更高为62.31倍。此外,使用小鼠踝肿胀试验(MAST),小鼠肿胀试验(MEST)和小鼠卷曲试验(MWT),对1:3 NMS / CMS的抗炎和镇痛作用进行系统性评价。结果表明,在掺入CMS后,NMS的治疗效果明显改善,所有药效学检测中的1:3 NMS / CMS的抑制率从102.2%变化至904.3%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号